Aktibong Pharmaceutical Ingredient
Progestogen at Estrogen | |||
Pangalan ng Produkto | Pagtutukoy | Naaprubahan | CAS No. |
Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolone | In-house |
Kosher | 145-13-1 |
Medroxyprogesterone Acetate | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrol Acetate | CP/EP/USP | DMF sa proseso | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Cyproterone Acetate | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | CEP/GMP | 797-63-7 |
Drospirenone | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF/GMP | 35380-71-3 |
Estriol | CP/EP/USP | Sa ilalim ng R&D | 50-27- 1 |
Ethinyl Estradiol | CP/EP/USP | GMP | 57-63-6 |
Estradiol Valerate | CP | DMF | 979-32-8 |
Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | EP | CEP | 65928-58-7 |
Fulvestrant | In-house | Sa ilalim ng R&D | 129453-61-8 |
Exemestane | EP/USP | Sa ilalim ng R&D | 107868-30-4 |
Androgen | |||
Pangalan ng Produkto | Pagtutukoy | Naaprubahan | CAS No. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
Testosterone Cypionate | USP | Sa ilalim ng R&D | 58-20-8 |
DHEA(Prasterone) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | DMF sa proseso | 19608-29-8 |
Cortical Hormone | |||
Pangalan ng Produkto | Pagtutukoy | Naaprubahan | CAS No. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF/GMP | 638-94-8 |
Eplerenone | EP | Nasa proseso ang CEP | 107724-20-9 |
Methylprednisolone | CP/EP/USP | DMF/GMP | 83-43-2 |
Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | In-house | DMF sa proseso | 397864-44-7 |
Mometasone Furoate |
EP/USP |
DMF sa proseso |
Walang tubig (83919-23-7) Monohydrate (141646-00-6) |
Ang iba | |||
Pangalan ng Produkto | Pagtutukoy | Naaprubahan | CAS No. |
Oxcarbazepine | CP/EP/USP | CEP/FDA | 28721-07-5 |
Eslicarbazepine Acetate | In-house | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP | DMF | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | In-house | Sa ilalim ng R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF/FDA | 656247-18-6 |
Revefenacin | In-house | DMF | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalate | EP/USP/CP | DMF sa proseso | 219861-08-2 |
Cariprazine Hydrochloride | In-house | DMF | 1083076-69-0 |
Lasmiditan Succinate | In-house | DMF | 439239-92-6 |
Luliconazole | In-house | DMF | 187164-19-8 |
Apalutami | In-house | DMF sa proseso | 956104-40-8 |
Tadalafil | EP/USP/CP | Sa ilalim ng R&D | 171596-29-5 |
Relugolix | In-house | DMF sa proseso | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholic Acid | EP/USP/JP | Sa ilalim ng R&D | 128-13-2 |
Omega-3-Acid Ethyl Ethers 90 |
EP/USP |
DMF sa proseso |
—— |
Medium-Chain Triglycerides |
CP/USP/EP |
DMF |
—— |
Benzalkonium Chloride |
USP/EP/JP |
Nasa proseso ang CEP |
8001-54-5 |
Langis ng Oliba (Para sa Iniksyon) |
CP/USP/EP/JP |
DMF sa proseso |
8001-25-0 |
Egg phospholipids (Para sa Injection) |
CP/USP/EP |
DMF |
93685-90-6 |
MERYenda |
In-house |
DMF sa proseso |
203787-91-1 |
Ang Abiraterone Acetate ay may mga pagtutukoy ng CP,USP. Available ang DMF, WC.
Ang Drospirenone ay may EP, mga pagtutukoy ng USP. Inaprubahan ng DMF.
Ang Medroxyprogesterone Acetate ay mayroong USPãEPã IPãJP at KP. Available ang DMF, GMP.
Ang Oxcarbazepine ay may mga detalye ng CP, EP at USP. Available ang CEP at DMF, inaprubahan ng GMP.
Ang Ganciclovir ay may CP ,EP, USP na detalye.Inaprubahan ng DMF at GMP.
Ang Nintedanib Esylate ay may in-house na detalye. Available ang DMF.